No association of a 306-bp insertion polymorphism in the progesterone receptor gene with ovarian and breast cancer
1997

No link between a specific gene variant and ovarian or breast cancer

Sample size: 543 publication Evidence: moderate

Author Information

Author(s): TP Manolitsas, P Englefield, D M Eccles, IG Campbell

Primary Institution: University of Southampton

Hypothesis

Does the 306-bp insertion polymorphism in the progesterone receptor gene associate with ovarian and breast cancer?

Conclusion

The study found no significant association between the PROGINS allele and ovarian or breast cancer.

Supporting Evidence

  • The study involved 231 ovarian cancer cases and 292 breast cancer cases.
  • No significant differences in allele distribution were found between cancer and control groups.
  • The findings contradict previous reports suggesting a link between the PROGINS allele and cancer.

Takeaway

The researchers looked at a gene variant to see if it was linked to ovarian and breast cancer, but they found no connection.

Methodology

The study assessed the frequency of the PROGINS allele in genomic DNA from ovarian cancer cases, breast cancer cases, and a control group using PCR.

Limitations

The study's findings contrast with previous studies that suggested an association, indicating potential limitations in sample size or population differences.

Participant Demographics

231 ovarian cancer cases, 292 breast cancer cases, and 220 healthy volunteers from southern England.

Statistical Information

P-Value

p=0.73 for breast cancer; p=0.86 for ovarian cancer

Confidence Interval

95% confidence intervals reported for allele frequencies

Statistical Significance

p=0.73 for breast cancer; p=0.86 for ovarian cancer

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication